Patents by Inventor Shane Manning

Shane Manning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240183872
    Abstract: Diagnostic instruments and methods of operating diagnostic instruments are provided. Methods of operating a diagnostic instrument includes providing the diagnostic instrument having one or more modules, wherein the one or more modules are configured to analyze specimens; providing a specimen sorter coupled to the diagnostic instrument; and sorting specimens into at least first group and a second group, wherein specimens in the first group are to be analyzed by at least one of the one or more modules, and specimens in the second group are not to be analyzed by any of the one or more modules. Other sorting methods and diagnostic instruments are provided.
    Type: Application
    Filed: March 25, 2022
    Publication date: June 6, 2024
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Muhammad Ahmed, Hadi Arbabi, Shane Manning, Navneet Jain
  • Publication number: 20210045561
    Abstract: Disclosed are nonlimiting examples of an accessory hanger. In one nonlimiting example embodiment an accessory hanger comprises an elastomeric strap having at least one hole, a hanger stem, at least one bracket on the hanger stem, the at least one bracket including a stud configured to insert into at least one hole of the elastomeric strap, a hanger body attached to the hanger stem, and at least one hanger hook attached to the hanger body.
    Type: Application
    Filed: June 18, 2020
    Publication date: February 18, 2021
    Inventor: Shane Manning
  • Patent number: 6403361
    Abstract: The method of the invention provides for the formation of a recombinant polypeptide which has been modified at the C-terminal end through the use of a transpeptidation process. The method is suitable for modifying recombinant polypeptides of any source including those which may be commercially available, those derived from recombinant single copy or multicopy polypeptide constructs, or those derived from single or multicopy recombinant fusion protein constructs. The transpeptidation reaction involves contacting an endopeptidase enzyme with a recombinant polypeptide to substitute an addition unit, of one or more amino acids, for a leaving unit, linked to a core polypeptide through a cleavage site recognized by the endopeptidase enzyme. Recombinant polypeptides derived from multicopy polypeptide constructs may be cleaved from the multicopy polypeptide at the N-terminal and C-terminal ends and simultaneously under go substitution of the leaving unit by the desired addition unit.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: June 11, 2002
    Assignee: Restoragen, Inc.
    Inventors: Fred W. Wagner, Jay Stout, Dennis Henriksen, Bruce Partridge, Shane Manning
  • Patent number: 6037143
    Abstract: The method of the invention provides for the formation of a recombinant polypeptide which has been modified at the C-terminal end through the use of a transpeptidation process. The method is suitable for modifying recombinant polypeptides of any source including those which may be commercially available, those derived from recombinant single copy or multicopy polypeptide constructs, or those derived from single or multicopy recombinant fusion protein constructs. The transpeptidation reaction involves contacting an endopeptidase enzyme with a recombinant polypeptide to substitute an addition unit, of one or more amino acids, for a leaving unit, linked to a core polypeptide through a cleavage site recognized by the endopeptidase enzyme. Recombinant polypeptides derived from multicopy polypeptide constructs may be cleaved from the multicopy polypeptide at the N-terminal and C-terminal ends and simultaneously under go substitution of the leaving unit by the desired addition unit.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: March 14, 2000
    Assignee: BioNebraska, Inc.
    Inventors: Fred W. Wagner, Jay Stout, Dennis Henriksen, Bruce Partridge, Shane Manning
  • Patent number: 5707826
    Abstract: The method of the invention provides for the formation of a recombinant polypeptide which has been modified at the C-terminal end through the use of a transpeptidation process. The method is suitable for modifying recombinant polypeptides of any source including those which may be commercially available, those derived from recombinant single copy or multicopy polypeptide constructs, or those derived from single or multicopy recombinant fusion protein constructs. The transpeptidation reaction involves contacting an endopeptidase enzyme with a recombinant polypeptide to substitute an addition unit, of one or more amino acids, for a leaving unit, linked to a core polypeptide through a cleavage site recognized by the endopeptidase enzyme. Recombinant polypeptides derived from multicopy polypeptide constructs may be cleaved from the multicopy polypeptide at the N-terminal and C-terminal ends and simultaneously under go substitution of the leaving unit by the desired addition unit.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 13, 1998
    Assignee: BioNebraska, Incorporated
    Inventors: Fred W. Wagner, Jay Stout, Dennis Henriksen, Bruce Partridge, Shane Manning
  • Patent number: 5512459
    Abstract: The method of the invention provides for the formation of a recombinant polypeptide which has been modified at the C-terminal end through the use of a transpeptidation process. The method is suitable for modifying recombinant polypeptides of any source including those which may be commercially available, those derived from recombinant single copy or multicopy polypeptide constructs, or those derived from single or multicopy recombinant fusion protein constructs. The transpeptidation reaction involves contacting an endopeptidase enzyme with a recombinant polypeptide to substitute an addition unit, of one or more amino acids, for a leaving unit, linked to a core polypeptide through a cleavage site recognized by the endopeptidase enzyme. Recombinant polypeptides derived from multicopy polypeptide constructs may be cleaved from the multicopy polypeptide at the N-terminal and C-terminal ends and simultaneously under go substitution of the leaving unit by the desired addition unit.
    Type: Grant
    Filed: July 20, 1993
    Date of Patent: April 30, 1996
    Assignee: BioNebraska, Inc.
    Inventors: Fred W. Wagner, Jay Stout, Dennis Henriksen, Bruce Partridge, Shane Manning